Tirzepatide Cost: List Price, Coupons, and Coverage

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This PlexusDx Education Hub article addresses GLP-1 pricing, weight-management protocols, and the genetics that shape metabolic outcomes. See the full Peptides & GLP-1 library.

Tirzepatide is the molecule behind more than one brand, so pricing questions about it can feel scattered. Looking at cost at the molecule level cuts through that: the same active ingredient sits inside different branded products, and the out-of-pocket figure is determined less by the name than by insurance design, the indication, and savings eligibility. This page organizes those drivers so the numbers make sense.

The molecule and its list price

Tirzepatide carries a U.S. list price of approximately $1,069 per month as of April 2026, per Eli Lilly published pricing. List price is the pre-insurance benchmark, sitting ahead of rebates, savings cards, and pharmacy negotiation. It is rarely what an insured patient pays, which is why molecule-level and brand-level cost quotes online can look inconsistent.

Insurance design and the indication written

Commercial coverage depends on the FDA-approved indication on the prescription and on the plan's formulary and prior authorization criteria. Type 2 diabetes coverage is common; chronic weight-management coverage is more variable, frequently subject to BMI-based prior authorization, and sometimes excluded. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though some cardiovascular indications are covered for certain products.

Manufacturer savings and pharmacy coupons

Eli Lilly publishes a manufacturer savings card that can substantially cut monthly out-of-pocket cost for eligible commercially insured patients, with the usual exclusions for Medicare, Medicaid, TRICARE, and other government funding, plus monthly and annual caps. GoodRx, SingleCare, and similar platforms list pharmacy-specific coupon prices. Because all of these terms shift, verify them when the prescription is filled.

Out-of-pocket, scenario by scenario

With commercial coverage of the indication and a savings card applied, eligible patients may pay as little as $25 per month depending on plan terms and caps. Without indication coverage, cash-pay cost sits near list price minus any coupon. Uninsured cost approaches list price, and compounded alternatives via PlexusDx Weight Management Protocols follow a separate pricing structure published per product.

Compounded tirzepatide and the shortage change

During the FDA-declared shortages, 503A pharmacies legally compounded semaglutide and tirzepatide. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing that window while leaving legitimate compounding pathways intact where clinically justified. Compounded products are not identical to brand products and are priced separately, so cost comparisons should account for those real differences.

The genetic layer under the price

PlexusDx offers tirzepatide and semaglutide through its Weight Management Protocols as Tirzepatide Injection and Tirzepatide Oral. Before any spend, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R variants that shape appetite and energy balance. It does not predict drug response; it lets you test before you invest. For related reading, see Mounjaro price without insurance and Mounjaro compound.

Why molecule-level cost still varies by brand and indication

Even though tirzepatide is a single molecule, the cost you encounter depends heavily on which branded product carries it and what indication your prescription names. The same active ingredient may be dispensed for type 2 diabetes or for weight management, and plans treat those two situations very differently for both coverage and prior authorization. That is why a molecule-level price range is a helpful anchor but never a final answer. The number that matters is the one attached to your specific product, indication, plan, and pharmacy on the day you fill, after any prior authorization has been decided and any savings card applied. Keeping the molecule in view helps you compare options intelligently and avoid assuming that a brand name alone dictates cost. Still, the last mile of what you pay is always determined by those individual coverage details rather than by the chemistry, so the most dependable figure comes from your own pharmacy running your exact prescription against your active plan rather than from a general estimate.

Frequently Asked Questions

How much does tirzepatide cost per month?

The U.S. list price is approximately $1,069 per month as of April 2026, per Eli Lilly published pricing. Insurance, savings cards, and pharmacy pricing can substantially change what a patient pays at the counter, so confirm the current price directly with the pharmacy before filling.

Is tirzepatide covered by insurance?

Coverage turns on the plan, its formulary, the FDA indication on the prescription, and prior authorization rules. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while weight-management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

What savings options exist?

Eli Lilly publishes a manufacturer savings card for eligible commercially insured patients that can lower monthly cost to as little as $25 under some plans. Government-insurance patients are usually excluded. Independent coupon platforms also publish prices, but terms change, so check current details at the time of fill.

How do compounded prices compare?

Compounded tirzepatide is priced separately from brand products, but it is legally and factually different, not a generic, and its quality varies by pharmacy. PlexusDx offers tirzepatide and semaglutide through its Weight Management Protocols, with per-protocol pricing published on each product page rather than a single headline number.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.